# Zhejiang Yanglin Biotechnology

Zhejiang Yanglin Biotechnology is a Corporate Investor based in Hangzhou, China.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Hangzhou, China
- **Region:** Asia
- **Address:** Hangzhou, Zhejiang, China
- **Assets under management:** Undisclosed
- **Website:** https://dnalab.com.cn

## Regulatory record

- **Reports private funds:** No

## About

Zhejiang Yanglin Biotechnology is a corporate investor based in Hangzhou, China. It focuses on investments in Asia. The firm has committed to one fund.

## Sectors

- Biotechnology
- Healthcare Services

## People

- Chairman (Name Undisclosed) — Chairman

## Questions

### What investment stages does Zhejiang Yanglin Biotechnology target?

The firm's mandate covers the full venture lifecycle: seed, start-up, expansion, and late-stage venture. This broad stage coverage allows it to support companies from preclinical research through to commercialization. Typical corporate biotech investors in China maintain wide stage flexibility to capture innovation early while reserving capacity for later-stage de-risked assets closer to market.

### Is Zhejiang Yanglin Biotechnology structured as a standalone fund or a balance-sheet investor?

The firm operates as a balance-sheet investor, deploying capital directly from its parent company rather than raising discrete funds from external limited partners. This structure gives it permanent capital and removes the fundraising cycle constraints that shape behavior at traditional venture firms, but also limits public transparency since no fund documents are filed with regulators.

## Related profiles

- [Zhejiang XCC Group](https://altss.com/profile/zhejiang-xcc-group)
- [Zhejiang Yixing Industry](https://altss.com/profile/zhejiang-yixing-industry)

---

Last updated: 2026-08-10T23:49:37.812Z

Canonical page: https://altss.com/profile/zhejiang-yanglin-biotechnology

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology